SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-19-000037
Filing Date
2019-07-31
Accepted
2019-07-30 19:13:12
Documents
84
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-2019630x10q.htm   iXBRL 10-Q 3032923
2 LETTER AGREEMENT BETWEEN AMGEN INC. AND UCB CELLTECH amgn-ex282019630xq2.htm EX-10.28 15307
3 RULE 13A-14(A) CERTIFICATIONS amgn-ex312019630xq2.htm EX-31 23781
4 SECTION 1350 CERTIFICATIONS amgn-ex322019630xq2.htm EX-32 10894
  Complete submission text file 0000318154-19-000037.txt   12660489

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20190630.xsd EX-101.SCH 55302
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20190630_cal.xml EX-101.CAL 88454
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20190630_def.xml EX-101.DEF 300089
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20190630_lab.xml EX-101.LAB 720026
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20190630_pre.xml EX-101.PRE 439041
10 EXTRACTED XBRL INSTANCE DOCUMENT amgn-2019630x10q_htm.xml XML 3246692
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 19986900
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences